Downstream Clot Fragment Migration During Endovascular Clot Extraction Adversely Affects Clinical Outcome (P4.212)

Conclusion: Our results strongly suggest an adverse effect of downstream clot fragments. Awareness of this should become part of the approval and post-marketing evaluation of devices.Disclosure: Dr. Frey has received personal compensation for activities with Boehringer Ingelheim Pharmaceuticals, Inc., Bristol-Myers Squibb Co., EKT Pharma, Genentech Inc., and Sanofi-Aventis Pharmaceuticals Inc. Dr. Darbonne has nothing to disclose. Dr. Clark has nothing to disclose. Dr. Tucker has nothing to disclose. Dr. Chapple has nothing to disclose.

http://www.neurology.org/cgi/content/short/82/10_Supplement/P4.212?rss=1

Source: Neurology - April 9, 2014 Category: Neurology Authors: Frey, J., Darbonne, C., Clark, J., Tucker, A., Chapple, C. Tags: Cerebrovascular Disease and Interventional Neurology: Acute Stroke Endovascular Source Type: research